ASCL1 and small cell lung carcinoma: NFIB can also be highly expressed in SCLC cells through the presence of atypically large enhancers or super-enhancers [13, 14] and NFIB is a target gene of ASCL1, a master regulator of neuroendocrine cell fate [14].